CLINICAL_TRIALS
withdrawal
· 2022-10-19
Clinical Trial Update: Paediatric Arteriopathy Steroid Aspirin Project [Phase 3]
Summary
Phase 3 pediatric trial on Arterial Ischemic Stroke investigating a steroid- aspirin approach has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Arterial Ischemic Stroke | Phase 3 | Status: WITHDRAWN